Intellicure partners with Smith+Nephew to Deliver In‐chart Ordering of RENASYS^◊ GO Negative Pressure Wound Therapy

Users of the innovative wound care EHR can order Smith+Nephew’s leading negative pressure wound therapy system without additional forms, tasks.

THE WOODLANDS (Aug. 19, 2020) – Intellicure, a pioneering wound care EHR company, has announced a partnership with Smith+Nephew, to allow for in‐chart ordering of its RENASYS GO system using Intellicure’s durable medical equipment (DME) tool called OrderTrak.

The partnership gives wound clinics a time‐efficient, reimbursement‐optimizing method for ordering the at‐home NPWT system, delivering positive outcomes for patients in a timely, hassle‐free manner.

“We believe in offering only the highest quality wound care equipment via the OrderTrak tool,” said Matt Pine, Chief Operating Officer of Intellicure. “Smith+Nephew’s supreme focus on positive wound outcomes make them a great partner.”

According to its users, Intellicure’s OrderTrak tool reduces clinicians’ time spent on administrative tasks by more than 45 minutes a day. OrderTrak automatically generates robust supporting documentation for DME orders and sends those orders directly to DME suppliers. Payers receiving documentation generated by Intellicure typically authorize the order payment quicker than DME orders made outside of Intellicure, which means the patient receives their at‐home treatment equipment, like the RENASYS GO System, in a timely fashion with minimal hassle and out‐of‐pocket expense.

“Intellicure’s impressive wound care software aligns with Smith+Nephew’s desire to deliver streamlined medical solutions that produce positive patient outcomes,” said Ryan Frank, VP US Wound Marketing at Smith+Nephew.

Intellicure’s OrderTrak tool is included free of charge to all Intellicure customers. As the physician visits with a patient and works in their chart, options for DME orders are presented based on the patient’s diagnosis, demographics, insurance, and more. All the physician does is click on the supplies the patient needs, verifies the order details with the patient, and signs off right there in the chart. The documentation for the order is automatically written and sent to the DME provider.

The patient’s order arrives at their door and the physician receives a notification that the order was delivered. It all happens automatically with a couple of clicks.

The RENASYS GO System is now included as a DME option within Intellicure’s OrderTrak module effective July 1 and orders of the leading negative pressure wound therapy system will be fulfilled by Rotech Healthcare, Inc.

For more information on the OrderTrak tool, visit Intellicure.com/ordertrak. For more information on the RENASYS GO System, contact your local Smith+Nephew Representative.

About Intellicure

Intellicure is the premier wound care software used by America’s elite wound clinics. Intellicure customers enjoy the cleanest clinical workflow, richest regulatory compliance, unparalleled reimbursement rates, and are recognized by CMS as the leaders in quality patient care. Visit Intellicure.com for more.

About Smith+Nephew

Smith+Nephew is a portfolio medical technology business that exists to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,500+ employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.1 billion in 2019. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on

Twitter, LinkedIn, Instagram or Facebook.

◊Trademark of Smith & Nephew

All Trademarks acknowledged

RNNE2-21990-0720